Associated Papers
Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.
De Castro-Orós I et al.
Plos One, 2016
Pharmacologic profile of the Adnectin BMS-962476, a small protein biologic alternative to PCSK9 antibodies for low-density lipoprotein lowering.
Mitchell T et al.
The Journal of Pharmacology and Experimental Therapeutics, 2014
Select a paper to view details